In a report released today, Lachlan Hanbury Brown from William Blair reiterated a Buy rating on ARS Pharmaceuticals (SPRY – Research Report).
Tri-Valley senior Kandice Spry changed her approach against highly regarded Carolyn Geckler at the state, but her title hopes ...
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ARS Pharmaceuticals (SPRY – Research Report) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback